TetraGenx. Revenue and Competitors
Estimated Revenue & Valuation
- TetraGenx.'s estimated annual revenue is currently $24.1M per year.
- TetraGenx.'s estimated revenue per employee is $201,000
Employee Data
- TetraGenx. has 120 Employees.
- TetraGenx. grew their employee count by 21% last year.
TetraGenx.'s People
Name | Title | Email/Phone |
---|
TetraGenx. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2591.1M | 8057 | 7% | N/A | N/A |
#2 | $13.1M | 65 | 5% | N/A | N/A |
#3 | $9.6M | 48 | -29% | N/A | N/A |
#4 | $12.5M | 62 | 9% | N/A | N/A |
#5 | $43.8M | 218 | 4% | N/A | N/A |
#6 | $1.8M | 18 | 64% | N/A | N/A |
#7 | $6.6M | 33 | -3% | N/A | N/A |
#8 | $11.7M | 58 | 12% | N/A | N/A |
#9 | $1104.4M | 3434 | 0% | $97M | N/A |
#10 | $21.3M | 106 | 7% | N/A | N/A |
What Is TetraGenx.?
TetraGenx streamline the pharmaceutical development cycle and the development of quality products by delivering quality Development and Analytical Services to the pharmaceutical and supporting industries. As the corporation grew, additional complimentary services and staff members were added to form a highly skilled organization. To this day, TetraGenx is the largest independent animal health company in North America and is 100% privately owned. TetraGenx operates out of two facilities in the Montreal, Quebec region. The company has established itself as a multi-disciplinary company providing a wide range of services to the animal health industry. Our success comes from our knowledge, experience, work ethics and our continuous awareness of industry standards.
keywords:Biotechnology,Healthcare,PharmaceuticalsN/A
Total Funding
120
Number of Employees
$24.1M
Revenue (est)
21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 128 | 19% | N/A |
#2 | $19.8M | 128 | 68% | N/A |
#3 | $26.3M | 131 | 7% | N/A |
#4 | N/A | 132 | 25% | N/A |
#5 | N/A | 134 | 49% | N/A |